Literature DB >> 21334234

In silico analysis of the binding of agonists and blockers to the β2-adrenergic receptor.

Santiago Vilar1, Joel Karpiak, Barkin Berk, Stefano Costanzi.   

Abstract

Activation of G protein-coupled receptors (GPCRs) is a complex phenomenon. Here, we applied Induced Fit Docking (IFD) in tandem with linear discriminant analysis (LDA) to generate hypotheses on the conformational changes induced to the β(2)-adrenergic receptor by agonist binding, preliminary to the sequence of events that characterize activation of the receptor. This analysis, corroborated by a follow-up molecular dynamics study, suggested that agonists induce subtle movements to the fifth transmembrane domain (TM5) of the receptor. Furthermore, molecular dynamics also highlighted a correlation between movements of TM5 and the second extracellular loop (EL2), suggesting that freedom of motion of EL2 is required for the agonist-induced TM5 displacement. Importantly, we also showed that the IFD/LDA procedure can be used as a computational means to distinguish agonists from blockers on the basis of the differential conformational changes induced to the receptor. In particular, the two most predictive models obtained are based on the RMSD induced to Ser207 and on the counterclockwise rotation induced to TM5. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21334234      PMCID: PMC3119336          DOI: 10.1016/j.jmgm.2011.01.005

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  48 in total

1.  Ligand-steered modeling and docking: A benchmarking study in class A G-protein-coupled receptors.

Authors:  Sharangdhar S Phatak; Edgar A Gatica; Claudio N Cavasotto
Journal:  J Chem Inf Model       Date:  2010-11-16       Impact factor: 4.956

2.  Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation.

Authors:  Wen Guo; Lei Shi; Marta Filizola; Harel Weinstein; Jonathan A Javitch
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-21       Impact factor: 11.205

Review 3.  The evasive nature of drug efficacy: implications for drug discovery.

Authors:  Ségolène Galandrin; Geneviève Oligny-Longpré; Michel Bouvier
Journal:  Trends Pharmacol Sci       Date:  2007-07-19       Impact factor: 14.819

4.  Human P2Y(6) receptor: molecular modeling leads to the rational design of a novel agonist based on a unique conformational preference.

Authors:  Stefano Costanzi; Bhalchandra V Joshi; Savitri Maddileti; Liaman Mamedova; Maria J Gonzalez-Moa; Victor E Marquez; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2005-12-29       Impact factor: 7.446

5.  Role of the second extracellular loop of adenosine receptors in agonist and antagonist binding. Analysis of chimeric A1/A3 adenosine receptors.

Authors:  M E Olah; K A Jacobson; G L Stiles
Journal:  J Biol Chem       Date:  1994-10-07       Impact factor: 5.157

Review 6.  Rhodopsin and the others: a historical perspective on structural studies of G protein-coupled receptors.

Authors:  Stefano Costanzi; Jeffrey Siegel; Irina G Tikhonova; Kenneth A Jacobson
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

7.  Computational mapping of the conformational transitions in agonist selective pathways of a G-protein coupled receptor.

Authors:  Supriyo Bhattacharya; Nagarajan Vaidehi
Journal:  J Am Chem Soc       Date:  2010-04-14       Impact factor: 15.419

8.  Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes.

Authors:  Vsevolod Katritch; Kimberly A Reynolds; Vadim Cherezov; Michael A Hanson; Christopher B Roth; Mark Yeager; Ruben Abagyan
Journal:  J Mol Recognit       Date:  2009 Jul-Aug       Impact factor: 2.137

Review 9.  The structure and function of G-protein-coupled receptors.

Authors:  Daniel M Rosenbaum; Søren G F Rasmussen; Brian K Kobilka
Journal:  Nature       Date:  2009-05-21       Impact factor: 49.962

10.  Involvement of Asn-293 in stereospecific agonist recognition and in activation of the beta 2-adrenergic receptor.

Authors:  K Wieland; H M Zuurmond; C Krasel; A P Ijzerman; M J Lohse
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

View more
  16 in total

Review 1.  New insights for drug design from the X-ray crystallographic structures of G-protein-coupled receptors.

Authors:  Kenneth A Jacobson; Stefano Costanzi
Journal:  Mol Pharmacol       Date:  2012-06-13       Impact factor: 4.436

2.  Structure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptors.

Authors:  J Robert Lane; Pavel Chubukov; Wei Liu; Meritxell Canals; Vadim Cherezov; Ruben Abagyan; Raymond C Stevens; Vsevolod Katritch
Journal:  Mol Pharmacol       Date:  2013-09-10       Impact factor: 4.436

Review 3.  Structure-function of the G protein-coupled receptor superfamily.

Authors:  Vsevolod Katritch; Vadim Cherezov; Raymond C Stevens
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-11-08       Impact factor: 13.820

4.  Understanding the effects on constitutive activation and drug binding of a D130N mutation in the β2 adrenergic receptor via molecular dynamics simulation.

Authors:  Yanyan Zhu; Yuan Yuan; Xiuchan Xiao; Liyun Zhang; Yanzhi Guo; Xuemei Pu
Journal:  J Mol Model       Date:  2014-10-25       Impact factor: 1.810

Review 5.  Diversity and modularity of G protein-coupled receptor structures.

Authors:  Vsevolod Katritch; Vadim Cherezov; Raymond C Stevens
Journal:  Trends Pharmacol Sci       Date:  2011-10-25       Impact factor: 14.819

6.  Rational design of 9-vinyl-phenyl noscapine as potent tubulin binding anticancer agent and evaluation of the effects of its combination on Docetaxel.

Authors:  Shruti Gamya Dash; Charu Suri; Praveen Kumar Reddy Nagireddy; Srinivas Kantevari; Pradeep Kumar Naik
Journal:  J Biomol Struct Dyn       Date:  2020-07-01

7.  GPCR agonist binding revealed by modeling and crystallography.

Authors:  Vsevolod Katritch; Ruben Abagyan
Journal:  Trends Pharmacol Sci       Date:  2011-09-06       Impact factor: 14.819

8.  In silico screening for agonists and blockers of the β(2) adrenergic receptor: implications of inactive and activated state structures.

Authors:  Stefano Costanzi; Santiago Vilar
Journal:  J Comput Chem       Date:  2011-12-14       Impact factor: 3.376

9.  Detailed analysis of biased histamine H₄ receptor signalling by JNJ 7777120 analogues.

Authors:  S Nijmeijer; H F Vischer; F Sirci; S Schultes; H Engelhardt; C de Graaf; E M Rosethorne; S J Charlton; R Leurs
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

10.  Conformation guides molecular efficacy in docking screens of activated β-2 adrenergic G protein coupled receptor.

Authors:  Dahlia R Weiss; SeungKirl Ahn; Maria F Sassano; Andrew Kleist; Xiao Zhu; Ryan Strachan; Bryan L Roth; Robert J Lefkowitz; Brian K Shoichet
Journal:  ACS Chem Biol       Date:  2013-03-21       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.